Prodromal Alzheimer disease
Item
patients with prodromal ad or mild to moderate ad
boolean
C3805054 (UMLS CUI [1])
Clinical dementia rating scale
Item
clinical dementia rating (cdr) score of 0.5, 1.0, or 2.0
boolean
C0451074 (UMLS CUI [1])
Impaired cognition
Item
have a cognitive impairment
boolean
C0338656 (UMLS CUI [1])
tau Proteins; cerebrospinal fluid
Item
low aβ and high tau in cerebrospinal fluid (csf)
boolean
C0085401 (UMLS CUI [1])
C0007806 (UMLS CUI [2])
Mini-mental state examination score
Item
mini mental state examination (mmse) score > 16 at screening
boolean
C2960235 (UMLS CUI [1])
Immunotherapy, Active; Alzheimers Disease
Item
previous active treatment with an ad immunotherapy in an investigational study
boolean
C0079612 (UMLS CUI [1])
C0002395 (UMLS CUI [2])
Concomitant Agent
Item
use of another investigational drug within 30 days of screening
boolean
C2347852 (UMLS CUI [1])
Comorbidity
Item
history or presence of clinically significant seizures, brain trauma, transient ischemic attack, and/or cerebrovascular disease
boolean
C0009488 (UMLS CUI [1])
comorbidity neurological
Item
presence of a neurological condition that could be contributing to cognitive impairment above and beyond that caused by the subject's ad
boolean
C0009488 (UMLS CUI [1,1])
C0205494 (UMLS CUI [1,2])
comorbidity; Dementia
Item
evidence of infection, tumor, or other clinically significant lesions that could indicate a dementia diagnosis other than ad
boolean
C0009488 (UMLS CUI [1])
C0497327 (UMLS CUI [2])